Literature DB >> 8146414

Nebulized colistin causes chest tightness in adults with cystic fibrosis.

J Maddison1, M Dodd, A K Webb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146414     DOI: 10.1016/0954-6111(94)90028-0

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  10 in total

Review 1.  Understanding non-compliance with treatment in adults with cystic fibrosis.

Authors:  M E Dodd; A K Webb
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Nebulisers for bronchiectasis.

Authors:  D C Currie
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Nebulised antibiotics for adults with cystic fibrosis.

Authors:  A K Webb; M E Dodd
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

4.  Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.

Authors:  Yu-Wei Lin; Qi Tony Zhou; Yang Hu; Nikolas J Onufrak; Siping Sun; Jiping Wang; Alan Forrest; Hak-Kim Chan; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis.

Authors:  M E Dodd; J Abbott; J Maddison; A J Moorcroft; A K Webb
Journal:  Thorax       Date:  1997-07       Impact factor: 9.139

Review 6.  Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.

Authors:  Garyphallia Poulakou; Dimitrios K Matthaiou; David P Nicolau; Georgios Siakallis; George Dimopoulos
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 7.  Nebulized antibiotics in cystic fibrosis.

Authors:  Isabelle Sermet-Gaudelus; Yann Le Cocguic; Agnés Ferroni; Marlène Clairicia; Joel Barthe; Jan-Pierre Delaunay; Valentine Brousse; Gérard Lenoir
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Authors:  Argyris Michalopoulos; Sofia K Kasiakou; Zefi Mastora; Kostas Rellos; Anastasios M Kapaskelis; Matthew E Falagas
Journal:  Crit Care       Date:  2005-01-06       Impact factor: 9.097

Review 9.  Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.

Authors:  Cordula Koerner-Rettberg; Manfred Ballmann
Journal:  Core Evid       Date:  2014-09-19

10.  Colistin and polymyxin B: a re-emergence.

Authors:  Sachin Gupta; Deepak Govil; Prem N Kakar; Om Prakash; Deep Arora; Shibani Das; Pradeep Govil; Ashima Malhotra
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.